39 results
8-K
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
the Company’s 2027 annual meeting of stockholders and thereafter until her successor has been duly elected and qualified or until her earlier death … death, resignation or removal. Dr. Thomas will also serve as a consultant to the Company, subject to and contingent and effective upon the closing
8-K
EX-99.2
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
tissues, causing inflammation, organ damage, debilitating symptoms and, in severe cases, death. To date there are over 100 documented autoimmune
DEFA14A
ELYM
Eliem Therapeutics Inc
12 Jun 24
Additional proxy soliciting materials
4:42pm
and thereafter until her successor has been duly elected and qualified or until her earlier death, resignation or removal. Dr. Brennan was not appointed … of stockholders and thereafter until his successor has been duly elected and qualified or until his earlier death, resignation or removal. Dr. Thomas
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
12 Jun 24
Departure of Directors or Certain Officers
4:41pm
separation from service, or (ii) as soon as practicable following your death, as may be permitted or required under Section 409A. The parties
8-K
ELYM
Eliem Therapeutics Inc
12 Jun 24
Departure of Directors or Certain Officers
4:41pm
elected and qualified or until her earlier death, resignation or removal. Dr. Brennan was not appointed to serve on any committees of the Eliem Board … earlier death, resignation or removal. Dr. Thomas was not appointed to serve on any committees of the Eliem Board.
In addition, subject
DEFM14A
iwl1q00jj82 f8
4 Jun 24
Proxy related to merger
8:00am
PREM14A
vdd6gf
17 May 24
Preliminary proxy related to merger
4:36pm
DEFA14A
bb0 842dy
11 Apr 24
Additional proxy soliciting materials
8:10am
8-K
EX-10.3
t8liigga
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
DEF 14A
se3arkpqucqzf5k yqy
8 Apr 22
Definitive proxy
4:20pm
8-K
EX-3.1
nqwop87
12 Aug 21
Amendments to Articles of Incorporation or Bylaws
5:25pm
424B4
8m0zqmo 4k
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
bhhvbs7cn5cl69m1le
2 Aug 21
IPO registration (amended)
6:08am